{"transactions":[{"id":4273574,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":174959,"kind":"person","name":"Feldman Maria","position":1,"cik":"0001674083","reported_name":"Feldman Maria","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Clinical Research"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-23T16:00:26.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shares vest and become exercisable in twenty-four (24) successive equal monthly installments measured from June 22, 2017."}],"balance_after":140000,"derivative":{"exercise_price":2.27,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001209191-17-041626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674083/000120919117041626/doc4.xml","form_type":"4"}},{"id":4400573,"issuer":{"id":8607,"kind":"organization","name":"Evofem Biosciences, Inc."},"owners":[{"id":174959,"kind":"person","name":"Feldman Maria","position":1,"cik":"0001674083","reported_name":"Feldman Maria","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP Clinical Research & Operati"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T15:55:34.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control."}],"balance_after":90000,"derivative":{"exercise_price":1.43,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001618835-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674083/000161883517000002/primary_doc.xml","form_type":"4"}}]}